The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.

Abstract

Cell-penetrating peptides (CPPs) are small peptides (typically 5-25 amino acids), which are used to facilitate the delivery of normally non-permeable cargos such as other peptides, proteins, nucleic acids, or drugs into cells. However, several recent studies have demonstrated that the TAT CPP has neuroprotective properties. Therefore, in this study, we assessed the TAT and three other CPPs (penetratin, Arg-9, Pep-1) for their neuroprotective properties in cortical neuronal cultures following exposure to glutamic acid, kainic acid, or in vitro ischemia (oxygen-glucose deprivation). Arg-9, penetratin, and TAT-D displayed consistent and high level neuroprotective activity in both the glutamic acid (IC50: 0.78, 3.4, 13.9 μM) and kainic acid (IC50: 0.81, 2.0, 6.2 μM) injury models, while Pep-1 was ineffective. The TAT-D isoform displayed similar efficacy to the TAT-L isoform in the glutamic acid model. Interestingly, Arg-9 was the only CPP that displayed efficacy when washed-out prior to glutamic acid exposure. Neuroprotection following in vitro ischemia was more variable with all peptides providing some level of neuroprotection (IC50; Arg-9: 6.0 μM, TAT-D: 7.1 μM, penetratin/Pep-1: >10 μM). The positive control peptides JNKI-1D-TAT (JNK inhibitory peptide) and/or PYC36L-TAT (AP-1 inhibitory peptide) were neuroprotective in all models. Finally, in a post-glutamic acid treatment experiment, Arg-9 was highly effective when added immediately after, and mildly effective when added 15 min post-insult, while the JNKI-1D-TAT control peptide was ineffective when added post-insult. These findings demonstrate that different CPPs have the ability to inhibit neurodamaging events/pathways associated with excitotoxic and ischemic injuries. More importantly, they highlight the need to interpret neuroprotection studies when using CPPs as delivery agents with caution. On a positive note, the cytoprotective properties of CPPs suggests they are ideal carrier molecules to deliver neuroprotective drugs to the CNS following injury and/or potential neuroprotectants in their own right.

• Authors: Bruno P Meloni, Amanda J Craig, Nadia Milech, Richard M Hopkins, Paul M Watt, Neville W Knuckey
• Journal: Cellular and molecular neurobiology (Cell Mol Neurobiol) Vol. 34 Issue 2 Pg. 173-81 (Mar 2014) ISSN: 1573-6830 [Electronic] United States
• PMID: 24213248 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Carrier Proteins
• Cell-Penetrating Peptides
• Gene Products, tat
• Neuroprotective Agents
• Neurotoxins
• Oligopeptides
• Pep-1 peptide
• Peptides
• nonaarginine
• Glutamic Acid
• Cysteamine
• penetratin
• Kainic Acid

Topics

• Amino Acid Sequence
• Animals
• Carrier Proteins (chemistry, pharmacology)
• Cell Survival (drug effects)
• Cell-Penetrating Peptides (chemistry, pharmacology)
• Cells, Cultured
• Cerebral Cortex (pathology)
• Cysteamine (analogs & derivatives, chemistry, pharmacology)
• Gene Products, tat (chemistry, pharmacology)
• Glutamic Acid (toxicity)
• Inhibitory Concentration 50
• Ischemia (pathology)
• Kainic Acid (toxicity)
• Models, Biological
• Molecular Sequence Data
• Neurons (drug effects, metabolism, pathology)
• Neuroprotective Agents (pharmacology)
• Neurotoxins (toxicity)
• Oligopeptides (chemistry, pharmacology)
• Peptides (chemistry, pharmacology)
• Rats
• Rats, Sprague-Dawley